---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-292635"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2021-10-06T23:59:59+00:00"
generated_at: "2026-06-28T22:36:18.560767+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Pieris Pharmaceuticals appoints Tom Bures as CFO, Ahmed Mousa as Chief Business Officer

## Summary
- Tom Bures promoted to CFO effective Oct 6, 2021; previously VP Finance and Treasurer.
- Ahmed Mousa promoted to Chief Business Officer & General Counsel; previously SVP Corporate Operations and GC.
- Bures base salary $370k, Mousa base $385k; each eligible for up to 40% annual bonus.
- Severance: 9 months base for without-cause; change of control: 12 months base + target bonus + full vesting.

## SEC filing metadata
- accession: 0001193125-21-292635
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2021-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000119312521292635/0001193125-21-292635-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000119312521292635/d206195d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-292635
- JSON: https://secwatch.observer/filing/0001193125-21-292635.json
- Plain text: https://secwatch.observer/filing/0001193125-21-292635.txt

## Key facts
- Executive change
  Thomas Bures was appointed as Senior Vice President and Chief Financial Officer at PALVELLA THERAPEUTICS, INC..
  - Action: appointed
  - Role: Senior Vice President and Chief Financial Officer
  source text: the Board appointed Mr. Thomas Bures, the Company’s Vice President, Finance and Treasurer, as Senior Vice President and Chief Financial Officer, effective as of October 6, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583648/000119312521292635/0001193125-21-292635-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.